{
    "paper_id": "c2f85462de13ceff6b9780ba2a6055d82ba9c4b3",
    "metadata": {
        "title": "When Does Transaminitis Become Acute Hepatic Failure? What Is the Management of Transaminitis and Acute Hepatic Failure? When Does Transaminitis Become Acute Hepatic Failure?",
        "authors": [
            {
                "first": "Michelle",
                "middle": [
                    "A"
                ],
                "last": "Hieger",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "WellSpan Health, York Hospital",
                    "location": {
                        "settlement": "York",
                        "region": "PA",
                        "country": "USA"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Non-toxicological causes of acute liver failure are listed in Table 69 .1 [1] . Toxicological causes of acute liver failure are listed in Table 69 .2 [1] . Viral hepatitis is the most common cause of acute liver failure worldwide, while acetaminophen is the most common cause of acute liver failure in the United States [3] . Acute liver failure is a common pathway for many conditions and insults, leading to massive hepatic necrosis and/or loss of normal hepatic function.",
            "cite_spans": [
                {
                    "start": 74,
                    "end": 77,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 150,
                    "end": 153,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 320,
                    "end": 323,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [
                {
                    "start": 62,
                    "end": 70,
                    "text": "Table 69",
                    "ref_id": "TABREF0"
                },
                {
                    "start": 138,
                    "end": 146,
                    "text": "Table 69",
                    "ref_id": "TABREF0"
                }
            ],
            "section": "Acute Hepatic Failure"
        },
        {
            "text": "Acute liver failure can be classified into subgroups by acuity of encephalopathy. Hyperacute liver failure is encephalopathy within 1 week of jaundice onset. Acute liver failure is encephalopathy within 8-28 days of jaundice onset. Subacute liver failure is encephalopathy within 5-12 weeks of jaundice onset [4, 5] .",
            "cite_spans": [
                {
                    "start": 309,
                    "end": 312,
                    "text": "[4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 313,
                    "end": 315,
                    "text": "5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "Acute Hepatic Failure"
        },
        {
            "text": "Each subgroup has its own set of complications. Hyperacute and acute liver failure have an increased incidence of cerebral edema, but hyperacute liver failure patients are more likely to survive with supportive care, and acute liver failure patients are more likely to die without liver transplant. Subacute liver failure patients have increased mortality, less cerebral edema, and increased likelihood of portal hypertension, leading to ascites and renal failure [5] .",
            "cite_spans": [
                {
                    "start": 464,
                    "end": 467,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "Complications"
        },
        {
            "text": "Other complications from acute liver failure include [5] :",
            "cite_spans": [
                {
                    "start": 53,
                    "end": 56,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "Complications"
        },
        {
            "text": "\u2022 Bleeding (including exsanguination) \u2022 Cardiovascular derangements \u2022 Pulmonary and ventilatory derangements \u2022 Central nervous system dysfunction (temperature dysregulation causing hypothermia, disruption of the bloodbrain barrier, and increased intracranial pressure leading to encephalopathy) \u2022 Metabolic derangements \u2022 Infection",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Complications"
        },
        {
            "text": "The higher the number of complications, the more likely the patient will not survive [1] .",
            "cite_spans": [
                {
                    "start": 85,
                    "end": 88,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": "Complications"
        },
        {
            "text": "Overall, outcomes have improved due to earlier identification of causes, earlier initiation of treatment, improved intensive care, and improved transplant science. Formerly, mortality was 55-95%, and now mortality is 30-40% [4, 6] . \u2022 Acute liver failure is a common pathway for many conditions and insults, leading to massive hepatic necrosis and/or loss of normal hepatic function. \u2022 Transaminases can be elevated secondary to many intra-and extrahepatic causes. \u2022 The level of transaminitis should not be the sole determinant in management and disposition. \u2022 Patients with acute liver failure should be considered for early transfer to a liver transplant center, ideally prior to elevation in intracranial pressure or the development of severe coagulopathy.",
            "cite_spans": [
                {
                    "start": 224,
                    "end": 227,
                    "text": "[4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 228,
                    "end": 230,
                    "text": "6]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Complications"
        },
        {
            "text": "Liver failure generally results in laboratory abnormalities beyond transaminitis. Blood work in acute liver failure may show [1, 7] :",
            "cite_spans": [
                {
                    "start": 125,
                    "end": 128,
                    "text": "[1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 129,
                    "end": 131,
                    "text": "7]",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": "Laboratory Abnormalities"
        },
        {
            "text": "\u2022 Synthetic dysfunction, which is usually the first sign of impending liver failure -decreased albumin and clotting factor levels, increased coagulation profiles \u2022 Defects in gluconeogenesis -decreased serum glucose \u2022 Worsening toxicant metabolism -increased ammonia \u2022 Decreased hepatic excretory function -increased bilirubin \u2022 Decreased renal function -elevated creatinine from prerenal azotemia, acute tubular necrosis, and/or hepatorenal syndrome Table 69 .3 reviews the utility of labs, imaging, and other ancillary tests in the evaluation of potential acute hepatic failure [1, 3, 8] .",
            "cite_spans": [
                {
                    "start": 580,
                    "end": 583,
                    "text": "[1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 584,
                    "end": 586,
                    "text": "3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 587,
                    "end": 589,
                    "text": "8]",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [
                {
                    "start": 451,
                    "end": 459,
                    "text": "Table 69",
                    "ref_id": "TABREF0"
                }
            ],
            "section": "Laboratory Abnormalities"
        },
        {
            "text": "In the appropriate clinical setting, elevations in AST and ALT should prompt the clinician to consider rhabdomyolysis Not an all-inclusive list and order a creatinine kinase level. Rhabdomyolysis-induced transaminitis occurs secondary to AST (and some ALT) release from muscle breakdown. In the past, ALT was considered liver-specific, but ALT elevations may occur in patients with myopathy but no liver disease [9] . Hypoperfusion from other medical issues can lead to transaminitis as well.",
            "cite_spans": [
                {
                    "start": 412,
                    "end": 415,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [],
            "section": "Non-hepatic Transaminitis"
        },
        {
            "text": "The King's College Criteria is used to determine potential for liver transplant in both acetaminophen toxicity and other causes of acute liver failure.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prognostication"
        },
        {
            "text": "The Intracranial pressure Assess ICP if stage III-IV encephalopathy present. Cerebral edema is the most common cause of death ARDS adult respiratory distress syndrome, BUN blood urea nitrogen, CBC complete blood count, ECG electrocardiogram, ALF acute liver failure, GI gastrointestinal, ICP intracranial pressure, NAC N-acetylcysteine, PT prothrombin time The Acute Physiology and Chronic Health Evaluation III Score (APACHE III Score) may also identify those in need of liver transplant [11] .",
            "cite_spans": [
                {
                    "start": 489,
                    "end": 493,
                    "text": "[11]",
                    "ref_id": "BIBREF10"
                }
            ],
            "ref_spans": [],
            "section": "Prognostication"
        },
        {
            "text": "What Is the Management of Transaminitis and Acute Hepatic Failure?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prognostication"
        },
        {
            "text": "Initial management of acute transaminitis includes fluid resuscitation, pain management, and nausea management. Generally, the cause of transaminitis will determine treatment and disposition. Transaminase values alone do not determine disposition. Admission is recommended for higher-risk (elderly and pregnant) patients or when there is no response or poor response to supportive care. It is also recommended for bilirubin \u226520 mg/dL, PT >50% above normal, hypoglycemia, spontaneous bacterial peritonitis, new or worsening hepatic encephalopathy, hepatorenal syndrome, or coagulopathy with bleeding. Additionally, the patient should be admitted if the he or she cannot ambulate safely or if there is an unsafe home condition. Any patient with acetaminophen toxicity (using the Rumack-Matthew nomogram) should be admitted, even if the transaminases and coagulation factors are normal [8] .",
            "cite_spans": [
                {
                    "start": 883,
                    "end": 886,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "Transaminitis"
        },
        {
            "text": "Patients with acute liver failure should be considered for early transfer to a liver transplant center, ideally prior to intracranial pressure elevation or development of severe coagulopathy [1] . Prophylactic treatment of coagulopathy is unnecessary. Fresh frozen plasma or factor VII should be given if there is active bleeding or before invasive procedures [12] . Patients with grade IV encephalopathy generally require intubation. Providers should elevate the head of bed to 10-20 \u00b0 and consider avoiding positive end-expiratory pressure if possible (grade III recommendation) [13] . With cerebral edema, intracranial pressure monitoring and decompression may be necessary.",
            "cite_spans": [
                {
                    "start": 191,
                    "end": 194,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 360,
                    "end": 364,
                    "text": "[12]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 581,
                    "end": 585,
                    "text": "[13]",
                    "ref_id": "BIBREF12"
                }
            ],
            "ref_spans": [],
            "section": "Acute Hepatic Failure"
        },
        {
            "text": "Specific antidotes exist for acetaminophen toxicity (n-acetylcysteine) and for Amanita mushroom poisoning (silibinin and intravenous penicillin G). Shock liver will improve with the restoration of perfusion. Herpes causing transaminitis can be treated with acyclovir. Acute Budd-Chiari syndrome (thrombosis of the hepatic veins) can be treated with transjugular intrahepatic portosystemic shunt (TIPS), surgical decompression, or thrombolysis. Autoimmune hepatitis can be treated with steroids. Idiosyncratic drug-induced transaminitis can be treated with withdrawal of the drug. Rechallenge of the drug should not be performed unless there is no alternate therapy [1] .",
            "cite_spans": [
                {
                    "start": 665,
                    "end": 668,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": "Antidotes and Specific Treatments"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Toxicant-induced hepatic failure",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dalhoff",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Critical care toxicology",
            "volume": "",
            "issn": "",
            "pages": "385--408",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Adverse drug reactions in the ICU",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Burkhart",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Critical care toxicology",
            "volume": "",
            "issn": "",
            "pages": "693--741",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Essentials of emergency medicine",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "V"
                    ],
                    "last": "Aghababian",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Early indicators of prognosis in fulminant hepatic failure",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "O&apos;grady",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "Gastroenterology",
            "volume": "97",
            "issn": "2",
            "pages": "439--484",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Acute liver failure: redefining the syndromes",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "O&apos;grady",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Williams",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Lancet",
            "volume": "342",
            "issn": "8866",
            "pages": "273--278",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Acute liver failure",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Murali",
                    "suffix": ""
                },
                {
                    "first": "Narayanan",
                    "middle": [],
                    "last": "Menon",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "V"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Management of acute liver failure",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "O&apos;grady",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Williams",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "Schweiz Med Wochenschr",
            "volume": "116",
            "issn": "17",
            "pages": "541--545",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Tintinalli's emergency medicine: a comprehensive study guide",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Susan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "G"
                    ],
                    "last": "O&apos;mara",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Tintinalli",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "525--558",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Goldfrank's toxicologic emergencies",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Delaney",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "302--313",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Meta-analysis of performance of Kings's college hospital criteria in prediction of outcome in non-paracetamol-induced acute liver failure",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Mcphail",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Wendon",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Bernal",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Hepatol",
            "volume": "53",
            "issn": "3",
            "pages": "492--501",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "APACHE III score is superior to King's college hospital criteria, MELD score and APACHE II score to predict outcomes after liver transplantation for acute liver failure",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Fikatas",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Transplant Proc",
            "volume": "45",
            "issn": "6",
            "pages": "2295--301",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "M"
                    ],
                    "last": "Shami",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Liver Transpl",
            "volume": "9",
            "issn": "2",
            "pages": "138--181",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Suggested Resources \u2022 Interpretation of liver function tests",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Mu\u00f1oz",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Seminars in liver disease",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Acute liver failure",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Bernal",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wendon",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "N Engl J Med",
            "volume": "369",
            "issn": "",
            "pages": "2525--2559",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Overview of the indications and contraindications for liver transplantation. Cold Spring Harb Perspect Med",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Farkas",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hackl",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Schlitt",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "M. A. Hieger Section of Toxicology, Department of Emergency Medicine, WellSpan Health, York Hospital, York, PA, USA e-mail: mhieger@wellspan.org 69 Pearls and Pitfalls",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Non-toxicological causes of acute liver failure a Rare: Coxiella burnetii, Plasmodium falciparum, amebic abscesses, disseminated TB, Bacillus cereus EBV Epstein-Barr virus, CMV cytomegalovirus, TB tuberculosis, AMI acute myocardial infarction, PE pulmonary embolism, HELLP hemolysis, elevated liver enzymes, low platelets a Not an all-inclusive list Table 69.2 Toxicological causes of acute liver failure a aspirin, amoxicillin-clavulanate, azathioprine, infliximab, carbamazepine, captopril, tetracycline, zidovudine, dantrolene, herbal meds (kava), dapsone, diltiazem, statins, methimazole, MAOIs, methotrexate, nitrofurantoin, TCAs, phenothiazines, gold, propylthiouracil, isoniazid, rifampin, ketoconazole, methyldopa FHF fulminant hepatic failure, NSAIDs nonsteroidal anti-inflammatory drugs, MAOIs monoamine oxidase inhibitors, TCAs tricyclic antidepressants, MDMA 3,4-methylenedioxymethamphetamine, PCP phencyclidine, TCE trichloroethylene",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Imbalances are common. Abnormalities can cause arrhythmias and worsen encephalopathy. Hypophosphatemia is common in acetaminophen overdose BUN/creatinine Renal failure is frequent and affects management and prognosis. Etiology (e.g., toxic effect of ingested substances)Evaluate for vascular thrombosis and infection. Preparation for transplantation",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Stages of clinical hepatic encephalopathy",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}